Meptranactylmilprem

Meptranactylmilprem Brand names, Meptranactylmilprem Analogs

Meptranactylmilprem Brand Names Mixture

No information avaliable

Meptranactylmilprem Chemical_Formula

C₂₀H₂₃NS

Meptranactylmilprem RX_link

No information avaliable

Meptranactylmilprem fda sheet

Meptranactylmilprem msds (material safety sheet)

Meptranactylmilprem Synthesis Reference

No information avaliable

Meptranactylmilprem Molecular Weight

309.469 g/mol

Meptranactylmilprem Melting Point

< 25 ^oC

Meptranactylmilprem H₂O Solubility

Soluble as HCl salt

Meptranactylmilprem State

Liquid

Meptranactylmilprem LogP

5.7

Meptranactylmilprem Dosage Forms

Tablets (oral, 1 mg)

Meptranactylmilprem Indication

Used for the symptomatic treatment of parkinsonism.

Meptranactylmilprem Pharmacology

Metixene is a tertiary antimuscarinic with actions similar to those of atropine; it also has antihistaminic and direct antispasmodic properties. It is used for the symptomatic treatment of parkinsonism, including the alleviation of the extrapyramidal syndrome induced by other drugs such as phenothiazines, but, like other antimuscarinics, it is of no value against tardive dyskinesias. Metixene has been discontinued.

Meptranactylmilprem Absorption

Absorbed in the gastrointestinal tract following oral administration, however the extent of absorption is not known.

Meptranactylmilprem side effects and Toxicity

Signs of overdose include dilated and sluggish pupils, warm, dry skin, facial flushing, decreased secretions of the mouth, pharynx, nose, and bronchi, foul-smelling breath, elevated temperature, tachycardia, cardiac arrhythmias, decreased bowel sounds, urinary retention, delirium, disorientation, anxiety, hallucinations, illusions, confusion, incoherence, agitation, hyperactivity, ataxia, loss of memory, paranoia, combativeness, and seizures.

Meptranactylmilprem Patient Information

Meptranactylmilprem Organisms Affected

Humans and other mammals